TrialDigestive diseases and sciences2011

A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

Mark LametPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.